Medication-assisted treatment of adolescents with opioid use disorders

Pediatrics

Volumn 138, Issue 3, 2016, Pages

  Levy, Sharon ^c   Ryan, Sheryl A ^c   Gonzalez, Pamela K ^c   Patrick, Stephen W ^c   Quigley, Joanna ^c   Siqueira, Lorena ^c   Walker, Leslie R ^c   Faden, Vivian B ^a   Tau, Gregory ^b   Jarrett, Renee ^c  

^a National Institute of Alcohol Abuse and Alcoholism   (United States)

^b American Academy of Child and Adolescent Psychiatry   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; METHADONE; NALTREXONE; OPIATE;

ADOLESCENT BEHAVIOR; ADOLESCENT HEALTH; ARTICLE; BEHAVIOR CHANGE; DISEASE SEVERITY; DRUG EFFICACY; FOOD AND DRUG ADMINISTRATION; HEALTH CARE ACCESS; HEALTH PROGRAM; HUMAN; MENTAL HEALTH CARE; MORBIDITY; MORTALITY; OPIATE ADDICTION; PATIENT COUNSELING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

EID: 84985896598     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2016-1893     Document Type: Article

References (21)

1. Agency for Health Care Policy and Research Public Health Service. Acute pain management: operative or medical procedures and trauma (clinical practice guideline). Rockville, MD: Agency for Health Care Policy and Research; 1992. Available at: http:// archive. ahrq. gov/ clinic/ medtep/ acute. htm. Accessed November 11, 2014
2. The Joint Commission. Pain Management Fact Sheet. 2014. Available at: www. jointcommission. org/ topics/ pain- management. aspx. Accessed November 10, 2014
3. Volkow ND. America's addiction to opioids: heroin and prescription drug abuse. National Institute on Drug Abuse; May 14, 2014. Available at: www. drugabuse. gov/ about-nida/ legislativeactivities/ testimony-to-congress/ 2014/ americas-addiction-to-opioids-heroinprescription- drug-abuse. Accessed September 12, 2014
4. Substance Abuse and Mental Health Services Administration Office of Applied Studies. National Household Survey on Drug Abuse: Population Estimates 1992. Rockville, MD: Substance Abuse and Mental Health Services Administration; 1993. Available at: https:// babel. hathitrust. org/ cgi/ pt? id= mdp. 39015026207988;vi ew= 1up;seq= 89. Accessed March 1, 2016
5. Substance Abuse and Mental Health Services Administration. Results From the 2012 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2013
6. Muhuri PK, Gfroerer JC, Davies MC. Associations of nonmedical pain reliever use and initiation of heroin use in the United States. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2013. Available at: www. samhsa. gov/ data/ sites/ default/ files/ DR006/ DR006/ nonmedical-pain-reliever-use-2013. htm. Accessed November 5, 2014
7. Hedegaard H, Chen L-H, Warner M. Drug-poisoning deaths involving heroin: United States, 2000-2013. Hyattsville, MD: Centers for Disease Control and Prevention; 2015. Available at: www. cdc. gov/ nchs/ data/ databriefs/ db190. htm. Accessed October 26, 2015
8. Moss R, Munt B. Injection drug use and right sided endocarditis. Heart. 2003;89(5):577-581. Available at: http:// heart. bmj. com/ content/ 89/ 5/ 577. short. Accessed October 26, 2015
9. Summanen PH, Talan DA, Strong C, et al. Bacteriology of skin and soft-tissue infections: comparison of infections in intravenous drug users and individuals with no history of intravenous drug use. Clin Infect Dis. 1995;20(suppl 2):S279-S282. Available at: http:// cid. oxfordjournals. org/ content/ 20/ Supplement- 2/ S279. short. Accessed October 26, 2015
10. Tsui JI, Evans JL, Lum PJ, Hahn JA, Page K. Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users. JAMA Intern Med. 2014;174(12):1974-1981. Available at: www. pubmedcentral. nih. gov/ articlerender. fcgi? artid= 4506774& tool= pmcentrez& rendertype= abstract. Accessed October 26, 2015
11. Kosten TR, George TP. The neurobiology of opioid dependence: implications for treatment. Sci Pract Perspect. 2002;1(1):13-20. Available at: www. pubmedcentral. nih. gov/ articlerender. fcgi? artid= 2851054& tool= pmcentrez& rendertype= abstract. Accessed November 10, 2014
12. Substance Abuse and Mental Health Services Administration. Drug Addiction Treatment Act of 2000: Title XXXV, Section 3502 of the Children's Health Act of 2000. 2014. Available at: http:// buprenorphine. samhsa. gov/ titlexxxv. html. Accessed November 12, 2014
13. McCormick C. Suboxone and Subtex Approval Letter, vol. 732. Rockville, MD: Center for Drug Evaluation and Research; Food and Drug Administration; 2002
14. Kraus ML, Alford DP, Kotz MM, et al; American Society of Addiction Medicine. Statement of the American Society of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction. J Addict Med. 2011;5(4):254-263. Available at: www. ncbi. nlm. nih. gov/ pubmed/ 22042215. Accessed November 11, 2014
15. Marsch LA, Bickel WK, Badger GJ, et al. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial. Arch Gen Psychiatry. 2005;62(10):1157-1164
16. Woody GE, Poole SA, Subramaniam G, et al. Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial. JAMA. 2008;300(17):2003-2011. Available at: www. pubmedcentral. nih. gov/ articlerender. fcgi? artid= 2610690& tool= pmcentrez& rendertype= abstract. Accessed June 20, 2014
17. Matson SC, Hobson G, Abdel-Rasoul M, Bonny AE. A retrospective study of retention of opioid-dependent adolescents and young adults in an outpatient buprenorphine/naloxone clinic. J Addict Med. 2014;8(3):176-182
18. Schuman-Olivier Z, Weiss RD, Hoeppner BB, Borodovsky J, Albanese MJ. Emerging adult age status predicts poor buprenorphine treatment retention. J Subst Abuse Treat. 2014;47(3):202-212
19. Dreifuss JA, Griffin ML, Frost K, et al. Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study. Drug Alcohol Depend. 2013;131(1-2):112-118
20. Marsch LA, Stephens MAC, Mudric T, Strain EC, Bigelow GE, Johnson RE. Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence. Exp Clin Psychopharmacol. 2005;13(4):293-302
21. Knudsen HK, Abraham AJ, Roman PM. Adoption and implementation of medications in addiction treatment programs. J Addict Med. 2011;5(1):21-27. Available at: www. pubmedcentral. nih. gov/ articlerender. fcgi? artid= 3045214& tool= pmcentrez& rendertype= abstract. Accessed October 30, 2014